Novo Nordisk Annual Report 2021
Contents
Introducing Novo Nordisk Strategic Aspirations
Key risks Management
Consolidated statements
Additional information
Novo Nordisk Annual Report 2021 77
General terms and conditions of launched programmes
2021
Restricted stock units to employees
2020
Shares for Management Board
Shares for management group below
Management Board
Shares allocated to individual
employees
2019
2021
2020
2019
2021
2020
2019
2021
2020
2019
Number of shares awarded in the year (million)
Value per share at launch (DKK)
Total market value at launch (DKK million)
Performance and vesting period
Allocated to recipients
2.1
0.5
0.4
0.5
1.6
1.0
1.3
0.1
0.0
0.2
307
423
411
298
423
411
298
538
391
311
660
223
152
152
649
416
387
71
17
48
2019 to
2021 to
2020 to
2019 to
2021 to
2020 to
2019 to
2021 to
2020 to
2019 to
2023
2023
2023
Feb 2023
Amortisation period
3.5 years
Feb 2024
3 years
Feb 2024
4 years
2022
Feb 2023
4 years
2023
Feb 2024
3 years
2023
2022
2024
2023
2022
Feb 2024
Feb 2023
2024
2023
2022
4 years
4 years
3 years
3 years
3 years
Outstanding restricted stock units
(million)
Restricted stock units to employees
Shares for Management Board
Shares for management group below
Management Board
Shares allocated to individual
employees
Total
2021
2020
2019
2021
2020
2019
2021
2020
2019
2021
2020
2019
2021
2020
2019
Outstanding at the beginning of
the year
2.1
2.1
1.5
1.8
1.3
1.2
4.5
3.2
2.7
0.2
0.3
0.2
8.6
6.9
5.6
Released allocated shares
(0.1)
(0.0)
(1.4)
(0.3)
(0.1)
(0.4)
(0.6)
(0.2)
(0.7)
(0.1)
(0.1)
(0.1)
(1.1)
(0.4)
(2.6)
Cancelled allocated shares
(0.1)
(0.0)
(0.0)
(0.3)
(0.1)
(0.1)
(0.0)
(0.0)
(0.0)
(0.3)
(0.1)
(0.2)
Allocated in the year
2.1
0.5
0.4
0.5
1.6
1.0
1.3
0.1
0.0
0.2
2.2
1.4
4.1
Performance adjustment¹
0.2
0.2
0.3
0.6
0.0
0.5
0.8
Outstanding at the end of the year
2.0
2.1
2.1
2.2
1.8
1.3
5.5
4.5
3.2
0.2
0.2
0.3
9.9
8.6
6.9
1. The number of shares for Management Board and management group below Management board has been adjusted as the financial and non-financial targets set by the Board are expected to be exceeded for the 2021 programme. The number of shares for Management
Board and management group below Management board has been adjusted as the sales growth target set by the Board for the 2018 programme is exceeded and is expected to be exceeded for the 2019 and 2020 programmes.View entire presentation